BlackRock Fund Advisors has recently announced that it has increased stake in Inmode Ltd (NASDAQ:INMD) by 0.80%. After grabbing 4.8 million shares, the institutional investor is now in possession of 38268.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 5.77% having worth around $91.74 million. Moreover, SSgA Funds Management, Inc. increased its share by 54163.0 to have a control over 1.79 million shares. And LSV Asset Management raised its holdings to 1.63 million shares by acquiring 1.68 million shares or 2.02% of the stake.
Inmode Ltd (INMD) concluded trading on 12/06/23 at a closing price of $21.26, with 6.42 million shares of worth about $136.58 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -37.64% during that period and on Wednesday the price saw a loss of about -9.99%. Currently the company’s common shares owned by public are about 82.54M shares, out of which, 76.67M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
iShares Russell 2000 ETF, Delaware Ivy Small Cap Growth Fun, and Swedbank Robur Smalbolagsfond Glo are the top 3 mutual funds which are holding stakes in Inmode Ltd iShares Russell 2000 ETF is currently holding 1.8 million shares of worth totaling $34.4 million. The company recently came selling 18113.0 shares which brought its stake up to 2.16% of the company’s outstanding shares. Swedbank Robur Smalbolagsfond Glo, after selling 0.76 million shares, have now control over 0.91% of the stake in the company. It holds -0.24 million shares of worth $14.46 million.
Inmode Ltd (NASDAQ: INMD) started trading at $20.34, below -$3.28 from concluding price of the previous day. However, the stock later moved at a day high price of 22.05, or with a loss of -9.99%. Stock saw a price change of -10.67% in past 5 days and over the past one month there was a price change of 3.86%. Year-to-date (YTD), INMD shares are showing a performance of -40.45% which decreased to -42.01% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $18.57 but also hit the highest price of $48.25 during that period. The average intraday trading volume for Inmode Ltd shares is 2.16 million. The stock is currently trading -4.10% below its 20-day simple moving average (SMA20), while that difference is down -8.62% for SMA50 and it goes to -35.79% lower than SMA200.
BlackRock Fund Advisors acquired 4.8 million shares of Inmode Ltd having value of about $91.74 million. Data submitted at the U.S SEC by BlackRock Fund Advisors revealed that the firm now holds 38268.0 shares in the company valued at close to $813577.68, or have control over 0.80% stake in the company. Inmode Ltd (NASDAQ: INMD) currently have 82.54M outstanding shares and institutions hold larger chunk of about 70.43% of that. Holding of mutual funds in the company is about 24.43% while other institutional holders and individual stake holders have control over 47.48% and — of the stake respectively.
The stock has a current market capitalization of $1.77B and its 3Y-monthly beta is at 2.26. PE ratio of stock for trailing 12 months is 10.11, while it has posted earnings per share of $2.10 in the same period. Its PEG reads 1.60 and has Quick Ratio of 11.87 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for INMD, volatility over the week remained 5.22% while standing at 4.71% over the month.
Analysts are in expectations that Inmode Ltd (INMD) stock would likely to be making an EPS of $0.68 in the current quarter, while forecast for next quarter EPS is $0.53 and it is $2.69 for next year. For the current quarter EPS, analysts have given the company a lowest target $0.64 which is $0.71 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.78 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 4.62% while it is estimated to increase by 6.03% in next year. EPS is likely to shrink at an annualized rate of 6.30% for next 5-years, compared to annual growth of 70.78% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by UBS on November 03, 2023 offering a Neutral rating for the stock and assigned a target price range of between $52 and $24 to it.
